Revisiting the metabolic syndrome and paving the way for microRNAs in non-alcoholic fatty liver disease. (Q38202220)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24702768%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

title

Revisiting the metabolic syndrome and paving the way for microRNAs in non-alcoholic fatty liver disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24702768%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference

1 reference

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24702768%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Cecilia Rodrigues

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24702768%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Rui E. Castro

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24702768%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

author name string

Duarte M S Ferreira

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24702768%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

language of work or name

English

0 references

publication date

28 April 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24702768%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24702768%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

volume

281

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24702768%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

page(s)

2503-2524

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24702768%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24702768%20AND%20SRC:MED&resulttype=core&format=json

Human fatty liver disease: old questions and new insights

13 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Toward unraveling the complexity of simple epithelial keratins in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Liver and muscle in morbid obesity: the interplay of fatty liver and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

The Unfolded Protein Response, Degradation from Endoplasmic Reticulum and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

The unfolded protein response transducer IRE1α prevents ER stress-induced hepatic steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

The role of the gut microbiota in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

The burden of liver disease in Europe: a review of available epidemiological data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Incidence and natural course of fatty liver in the general population: the Dionysos study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Non-alcoholic fatty liver disease in older people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Epidemiology of non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Impact of fatty liver disease on health care utilization and costs in a general population: a 5-year observation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic Beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Cell signaling. Fat stress and liver resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Role of the intestinal microbiome in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Insulin signalling and the regulation of glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Contrasting effects of IRS-1 versus IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Irs1 serine 307 promotes insulin sensitivity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Insulin resistance: a metabolic pathway to chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

A central role for JNK in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Reactive oxygen species have a causal role in multiple forms of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Increased p85/55/50 expression and decreased phosphotidylinositol 3-kinase activity in insulin-resistant human skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Inducible liver-specific knockdown of protein tyrosine phosphatase 1B improves glucose and lipid homeostasis in adult mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced endoplasmic reticulum stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

PTP1B and TCPTP--nonredundant phosphatases in insulin signaling and glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Reactive oxygen species mediate the down-regulation of mitochondrial transcripts and proteins by tumour necrosis factor-alpha in L929 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Regulation of intracellular signalling through cysteine oxidation by reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Regulation of protein tyrosine phosphatases by reversible oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Reactive oxygen species enhance insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

High-fat-fed obese glutathione peroxidase 1-deficient mice exhibit defective insulin secretion but protection from hepatic steatosis and liver damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Fanconi anemia links reactive oxygen species to insulin resistance and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

IRE1 signaling affects cell fate during the unfolded protein response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Induction of liver steatosis and lipid droplet formation in ATF6alpha-knockout mice burdened with pharmacological endoplasmic reticulum stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Atf6α-null mice are glucose intolerant due to pancreatic β-cell failure on a high-fat diet but partially resistant to diet-induced insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Diabetes mellitus and exocrine pancreatic dysfunction in perk-/- mice reveals a role for translational control in secretory cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

PERK EIF2AK3 control of pancreatic beta cell differentiation and proliferation is required for postnatal glucose homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

PERK-dependent regulation of lipogenesis during mouse mammary gland development and adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Pharmacological inhibition of protein tyrosine phosphatase 1B: a promising strategy for the treatment of obesity and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

H2S-Induced sulfhydration of the phosphatase PTP1B and its role in the endoplasmic reticulum stress response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Increased ER-mitochondrial coupling promotes mitochondrial respiration and bioenergetics during early phases of ER stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

ER stress modulates cellular metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Mitochondria in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Transcriptional regulation of Bim by FoxO3A mediates hepatocyte lipoapoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

JNK1-dependent PUMA expression contributes to hepatocyte lipoapoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Host-bacterial mutualism in the human intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Mechanisms underlying the resistance to diet-induced obesity in germ-free mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

An obesity-associated gut microbiome with increased capacity for energy harvest

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

c-Jun N-terminal kinase 1/c-Jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Origins and Mechanisms of miRNAs and siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

MicroRNAs: target recognition and regulatory functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Regulation of mRNA translation and stability by microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Origin, biogenesis, and activity of plant microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

MicroRNAs in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Differential expression of microRNAs in mouse liver under aberrant energy metabolic status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Nonalcoholic fatty liver disease is associated with an altered hepatocyte microRNA profile in LDL receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

MicroRNA expression profile in Lieber-DeCarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

A putative role of micro RNA in regulation of cholesterol 7alpha-hydroxylase expression in human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Regulation of cholesterol and bile acid homeostasis by the cholesterol 7α-hydroxylase/steroid response element-binding protein 2/microRNA-33a axis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

A role for miR-296 in the regulation of lipoapoptosis by targeting PUMA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

MicroRNA-1 and microRNA-206 suppress LXRα-induced lipogenesis in hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 up-regulation in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

MiR-155 has a protective role in the development of non-alcoholic hepatosteatosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Activation of p53 enhances apoptosis and insulin resistance in a rat model of alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Aberrantly elevated microRNA-34a in obesity attenuates hepatic responses to FGF19 by targeting a membrane coreceptor β-Klotho

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Elevated microRNA-34a in obesity reduces NAD+ levels and SIRT1 activity by directly targeting NAMPT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Expression of genes for microRNA-processing enzymes is altered in advanced non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Detection of microRNA expression in human peripheral blood microvesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Plasma microRNA profiles in rat models of hepatocellular injury, cholestasis, and steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Characterization of microRNA expression profiles in normal human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Plasma microRNAs are sensitive indicators of inter-strain differences in the severity of liver injury induced in mice by a choline- and folate-deficient diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Upregulation of miR-15b in NAFLD models and in the serum of patients with fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

MicroRNAs in body fluids--the mix of hormones and biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

21 January 2018

MicroRNA therapeutics.

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Specificity, duplex degradation and subcellular localization of antagomirs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Silencing of microRNAs in vivo with 'antagomirs'

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Design of LNA probes that improve mismatch discrimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

MicroRNA-133 controls cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Enhanced hepatic delivery of siRNA and microRNA using oleic acid based lipid nanoparticle formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

miR-34 - a microRNA replacement therapy is headed to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Hepatocyte Apoptosis, Expression of Death Receptors, and Activation of NF-κB in the Liver of Nonalcoholic and Alcoholic Steatohepatitis Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806

Apoptosis and Bcl-2 expression in the livers of patients with steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12806